Beneficient (NASDAQ:BENF – Get Free Report) was the target of a significant decline in short interest in February. As of February 13th, there was short interest totaling 94,000 shares, a decline of 14.4% from the January 29th total of 109,788 shares. Based on an average daily trading volume, of 18,804 shares, the days-to-cover ratio is currently 5.0 days. Currently, 0.7% of the shares of the stock are sold short. Currently, 0.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 18,804 shares, the days-to-cover ratio is currently 5.0 days.
Beneficient Stock Performance
Shares of Beneficient stock opened at $4.11 on Friday. Beneficient has a 52-week low of $1.75 and a 52-week high of $12.48. The company’s 50 day moving average price is $4.81 and its 200-day moving average price is $4.73.
Hedge Funds Weigh In On Beneficient
An institutional investor recently raised its position in Beneficient stock. Geode Capital Management LLC lifted its holdings in Beneficient (NASDAQ:BENF – Free Report) by 154.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 154,257 shares of the company’s stock after buying an additional 93,709 shares during the quarter. Geode Capital Management LLC owned approximately 1.11% of Beneficient worth $1,084,000 as of its most recent SEC filing. 90.57% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
Featured Articles
- Five stocks we like better than Beneficient
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
